Browsing by Subject Heptanoic Acids/*pharmacology

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 6 of 6
TitleAuthor(s)Issue date???itemlist.???
Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIBTsimihodimos, V.; Karabina, S. A.; Tambaki, A. P.; Bairaktari, E.; Goudevenos, J. A.; Chapman, M. J.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) StudyAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Symeonidis, A. N.; Mercouris, B. R.; Pehlivanidis, A.; Bouloukos, V. I.; Elisaf, M. S.24-Nov-2015-
Effect of atorvastatin on serum creatinine levelsKakafika, A.; Liamis, G.; Elisaf, M. S.; Mikhailidis, D.24-Nov-2015-
Effect of atorvastatin on serum uric acid levelsKakafika, A.; Tsimihodimos, V.; Elisaf, M. S.24-Nov-2015-
Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatmentPapathanasiou, A. I.; Lourida, E. S.; Tsironis, L. D.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Statins and homocysteineMiltiadous, G.; Papakostas, J.; Chasiotis, G.; Seferiadis, K.; Elisaf, M. S.24-Nov-2015-